Innoblative Designs

Innoblative Designs is an emerging, privately-held medtech company focused on innovative surgical ablation technologies for oncology. Its core achievement is the SIRA® device, a radiofrequency ablation (RFA) tool cleared for use as an adjunct in breast-conserving surgery to provide localized margin control and reduce reoperation rates. The company is in the early commercial and clinical evidence generation stage, having secured critical regulatory approvals and a Category III CPT code, positioning it to address a significant need in breast cancer surgery. With a seasoned leadership team and multiple platform devices in development, Innoblative aims to expand its impact within soft tissue surgical oncology.

Radiofrequency ablation (RFA) platform for intraoperative coagulation and ablation of soft tissue, designed as single-use disposable applicators for use with standard electrosurgical generators.

Competition includes other intraoperative margin management technologies such as intraoperative radiation therapy (IORT) systems (e.g., Zeiss Intrabeam, Elekta IntraOp), cryoablation devices, and advanced pathology/imaging systems for frozen section analysis. Innoblative's SIRA® differentiates by using familiar RFA energy in a novel, single-use applicator designed for immediate cavity ablation, potentially offering a simpler and more cost-effective workflow integration compared to some alternatives.